Mylan recalls insulin pens with missing labels to prevent medication errors. Affected pens have specific NDC numbers and were sold with expiration dates through August 2023.
Labeling: Missing label: Label missing from some prefilled pens.
Mylan is recalling insulin pens that lack labels, which could lead to incorrect dosing. This is a safety issue for people using insulin injections.
Missing labels on insulin pens can cause incorrect dosing if the user tries to read the label without it. This is a labeling issue, not a physical defect in the pen itself.
People with diabetes who use insulin pens from this manufacturer are affected. Those who have the specific NDC numbers listed are most at risk.
Check for the NDC numbers 49502-394-71 (pens) and 49502-394-75 (cartons of 5 pens). These pens were sold with an expiration date of August 2023.
Look for a label on the pen; if missing, it is part of the recall.
The recall is for missing labels on some prefilled pens, which could lead to incorrect dosing.
Check if the label is missing; if so, stop using it and contact Mylan for instructions.
Yes, missing labels could cause incorrect dosing, but the pens themselves are safe to use if labeled properly.
We’ve drafted a message you can send Mylan to request your refund or repair — edit it as you like.
Subject: Recall D-1292-2022 — Mylan Mylan Hello, I own a Mylan that is covered by recall D-1292-2022 from Mylan. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
